NCT04511039 Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer Status RECRUITING Phase PHASE1
NCT04507776 Study To Evaluate The Efficacy And Long-Term Adherence Of Spondyloarthropathies(SpA) Patients On Enbrel Status COMPLETED Phase N/A
NCT04507763 Study To Evaluate The Impact Of Early Initiation Of Biological Treatment With Ankylosing Spondylitis Status COMPLETED Phase N/A
NCT04505410 Second Line Induction Therapy and Healthy Diet for Patients With Ulcerative Colitis Status COMPLETED Phase PHASE3
NCT04504201 Patient-centered Communication About Healthy Weight in Early Breast Cancer Status COMPLETED Phase N/A
NCT04498520 Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer Status WITHDRAWN Phase PHASE1
NCT04498481 TREATMENT AND MONITORING PATTERNS AND CLINICAL OUTCOMES IN PATIENTS RECEIVING PALBOCICLIB COMBINATION TREATMENT (WITH AI OR FULVESTRANT) FOR HR+/HER2- A/MBC IN A COMMUNITY ONCOLOGY SETTING. Status COMPLETED Phase N/A
NCT04498403 A Study of the Long-Term Safety of Crisaborole Ointment, 2% in Japanese Pediatric and Adult Participants With Mild to Moderate Atopic Dermatitis Status TERMINATED Phase PHASE3
NCT04495140 Study To Characterize Mass Balance, Absolute Bioavailability, Fraction Absorbed And Pharmacokinetics Of 14C PF-06882961 Status COMPLETED Phase PHASE1
NCT04494958 Palbociclib and Binimetinib in Advanced Triple Negative Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT04493203 Nivolumab Plus Axitinib in Patients With Anti-PD1 Refractory Advanced Melanoma Status COMPLETED Phase PHASE2
NCT04486625 Pharmacokinetic Study of Aztreonam-Avibactam in Severe Renal Impairment Status COMPLETED Phase PHASE1
NCT04486352 A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT04485325 Capability of Tofacitinib or Etanercept to Accelerate Tapering of NSAID and Treat-to-target Guided De-escalation of Corticosteroids in RA Patients Status COMPLETED Phase PHASE4
NCT04483505 Rogaratinib, Palbociclib y Fulvestrant in Patients With Breast Cancer. Status COMPLETED Phase PHASE1
NCT04478357 BIOEQUIVALENCE STUDY IN HEALTHY PARTICIPANTS COMPARING 4 MG AND 8 MG FESOTERODINE EXTENDED-RELEASE TABLETS (TOVIAZ™), MANUFACTURED AT ZWICKAU VERSUS FREIBURG Status COMPLETED Phase PHASE1